Bingham Private Wealth’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.1M Buy
4,346
+27
+0.6% +$6.29K 0.76% 33
2026
Q1
$1.06M Sell
4,319
-4,307
-50% -$1M 0.84% 32
2025
Q4
$755K Buy
+8,626
New +$1.71M 0.65% 37
2025
Q2
$574K Buy
8,728
+4,827
+124% +$742K 0.55% 52
2025
Q1
$647K Buy
3,901
+263
+7% +$41.2K 0.67% 46
2024
Q4
$526K Buy
+3,638
New +$564K 0.56% 58

Other funds holding JNJ

Bingham Private Wealth's JNJ Position: Q2 2026 in Review

Bingham Private Wealth increased its Johnson & Johnson (JNJ) stake by 0.63% in Q2 2026, buying an estimated $6.29K and bringing the position to 4,346 shares worth $1.1M. The position accounts for 0.76% of the portfolio, ranked #33.

Bingham Private Wealth first reported a position in JNJ in Q4 2024 and has held it in 6 quarters since. 4,685 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Bingham Private Wealth held 4,346 shares of Johnson & Johnson worth $1.1M as of Q2 2026.
  • Bingham Private Wealth bought 27 Johnson & Johnson shares in Q2 2026, an estimated $6.29K.
  • Johnson & Johnson made up 0.76% of Bingham Private Wealth's portfolio in Q2 2026, its #33 holding.
  • Bingham Private Wealth first reported a position in Johnson & Johnson in Q4 2024 and has held it in 6 quarters since.
  • 4,685 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Bingham Private Wealth's 13F filing for Q2 2026, filed 11 Aug 2026.